Days after its share price tumbled on fears that its ability to sell copycat weight-loss shots might be very short-lived, ...

Telehealth prescription company Hims & Hers has a new semaglutide initiative. The program will offer compounded semaglutide ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Hims & Hers Health is a telehealth company known for offering compounded alternatives to popular GLP-1 weight-loss treatments. Its shares have soared over 120% since August 2023. Also Read ...

The singer highlighted how she hoped her future partner wouldn't "care that much about keeping people out" Xavi Torrent/TAS24/Getty Images for TAS Rights Management Taylor Swift manifested a ...

U.S. telehealth company Hims & Hers Health said it will sell compounded versions of Novo Nordisk’s popular weight-loss drug Wegovy to patients in certain professions for $99 a month.

MINNEAPOLIS — If this was it, then maybe there was no more fitting way for it to end. Diana Taurasi fouled out one last time. As she walked to the bench, she shook her head at her coaches like, ...

Shares of healthcare company Hims & Hers Health (NYSE: HIMS) jumped as much as 23.9% this week after news of closing a large acquisition. According to data provided by S&P Global Market ...

NEW YORK (Reuters) - U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain ...

Hims & Hers Health Q3 2024 revenue projected to surpass estimates by $5M-$10M. Truist consumer survey shows 10% use compounded GLP-1 medications, while 14% prefer branded options. Thursday ...